No, the one the government signed up to is this one:
https://theconversation.com/what-is-sotrovimab-the-covid-drug-the-government-has-bought-before-being-approved-for-use-in-australia-165802
I don't think its the same as NOX, I'm definately no expert on either but it does highlight there is a lot of competition around and in those situations it difficult to get traction to get product into the market. I'm tracking some brilliant products and getting traction is really slow and costly.
Ann: NOX and US Govt Peak Cancer Agency Announce Collaboration, page-19
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $30.68M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $6.962K | 66.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 226945 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 38999 | 2 |
View Market Depth
| Last trade - 14.36pm 11/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |